By
AmyT on
April 16, 2010
If you can still get excited about diabetes research headlines, then here’s some exciting news coming out of Cambridge, Mass, this week: Tolerx, a life sciences company, has reported they are in Phase 3 clinical trials for a new treatment of type 1 diabetes. If everything goes to plan, a representative of the company says, Tolerx could launch the first-ever offering approved by the FDA to treat the cause of type 1 diabetes. Pretty cool!…
Read more »
By
AmyT on
April 15, 2010
Robert Oringer is currently Co-Chairman and Board Director of AMG Medical Inc. in Canada, which distributes professional and home healthcare products. But he’s also the man who pioneered private-label diabetes products in the US, including syringes, glucose products, and testing supplies.
One might call Robert a serial diabetes entrepreneur — and at least as importantly, father of two teenage boys with type 1 diabetes. We catch up with him today in his role as a…
Read more »
By
AmyT on
April 14, 2010
I’m sure many of you heard the news yesterday that Roche Diabetes has acquired Israel-based Medingo, makers of the much-anticipated Solo insulin patch pump — a would-be direct competitor to the OmniPod tubeless pumping system.
Roche paid $160 million for the small company and its technology, which is a drop in the bucket in industry terms. The press release predicts “worldwide availability by 2012.”
In case you’re wondering, the Solo system already had an integrated…
Read more »
By
AmyT on
April 13, 2010
Last week, my husband and I took the whole gang — three kids plus my oldest daughter’s best friend — on a roadtrip down to LA for Spring Break. Seven hours in the car is never a great experience, but now that their ages range from 7-12, it’s getting much less painless. (No one barfed! Not even me)
For our “roller coaster day” at Knott’s Berry Farm, my 12-year-old and her BFF wore a set of…
Read more »
